April 17, 2017

QXMédical Announces Sponsorship of Leading EVAR Planning Website

QXMédical teams up with EVARplanning.com to provide endovascular specialists with the first and only on-line EVAR planning tool.

ROSEVILLE, Minnesota (April 17, 2017) - QXMédical, LLC, an innovative global medical device company committed to developing and manufacturing first-in-class solutions for the endovascular, cardiovascular and trauma care markets, today announced its sponsorship of EVARplanning.com. This unique on-line tool helps vascular and cardiovascular specialists plan complex endovascular aortic repair (EVAR) procedures. Developed by Dr. Paolo Spada, endovascular surgeon at Humanitas Research Hospital in Milan, Italy, the website assists vascular specialists in planning the optimal EVAR or TEVAR procedure specific to the patient’s unique anatomy. Dr. Spada commented, “I thank QXMédical for choosing EVARplanning.com as a partner and, with their support, we will continue to improve our site and expand our user base.”

Introduced in 2014, the simple user-friendly app now includes an extensive database of the most frequently used aortic endografts and assists the user in selecting a case-optimized configuration based on a sophisticated algorithm. Fernando Di Caprio, CTO of QXMédical, said, “Dr. Spada and EVARplanning.com are committed to providing a free comprehensive on-line tool that helps the endovascular community plan complex EVAR procedures. This philosophy is aligned with QXMédical’s vision of simplifying the complex.”

With over 1300 members, the app has proven to be a useful tool for endovascular surgeons worldwide. In 2016, EVARplanning.com was recognized for its innovation by winning the BioUpper award for entrepreneurial ideas in the field of life science. Dr. Spada further commented, “We are passionate about our work and commitment to the endovascular community. We are working with excellent partners to develop a revolutionary machine learning system for the predictive planning and rendering of endovascular procedures, based on our global community experience.” Please visit www.evarplanning.com for additional information.

QXMédical has been involved in EVAR since 2009 with the introduction of its innovative balloon catheter technology. The QXMédical Q50® PLUS Stent Graft Balloon Catheter is a leading aortic endograft molding balloon with unique features making it ideal for both complex and straightforward procedures. The device is available in the US, Canada and Europe. Please visit www.qxmedical.com for additional information regarding the product.

About QXMédical, LLC

QXMédical (QXM) is an innovative global medical device company committed to developing and manufacturing state-of-the art solutions for in the endovascular, cardiovascular and trauma markets. Headquartered in Montreal, Canada, the company's R&D and manufacturing facilities are located n St. Paul, Minnesota. QXM serves a wide range of markets through various channels, including both direct sales and strategic partnerships. Please visit www.qxmedical.com to learn more about the company.

For additional information, contact:

Frank Panarello

QXMédical, LLC